Sha Yi
Impact in
-
- Natural product bioactivities and synthesis
- Ginseng Biological Effects and Applications
- Metabolomics and Mass Spectrometry Studies
- Biological Activity of Diterpenoids and Biflavonoids
- Ubiquitin and proteasome pathways
Papers in
-
- Natural product bioactivities and synthesis 14
- Biological Activity of Diterpenoids and Biflavonoids 5
- Plant Toxicity and Pharmacological Properties 4
- Bioactive Natural Diterpenoids Research 3
- Retinoids in leukemia and cellular processes 3
-
- Phytochemistry and Biological Activities 7
- Co-authors
- Lijing Yang (5 shared papers)Xian Li (5 shared papers)Guohui Cui (5 shared papers)Famei Li (1 shared paper)Shuang Cai (1 shared paper)Hailong Zhang (4 shared papers)Taoguang Huo (1 shared paper)Lubing Gu (4 shared papers)
- Journals
- Journal of Asian Natural Products Research (10 papers)Chemical and Pharmaceutical Bulletin (3 papers)International Immunopharmacology (2 papers)Acta Pharmacologica Sinica (2 papers)Annals of Hematology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Sha Yi
53 papers receiving 840 citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 534
- Complementary and alternative medicine 57
- Pharmacology 61
- Toxicology 21
- Cancer Research 67
Countries citing papers authored by Sha Yi
This map shows the geographic impact of Sha Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sha Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sha Yi more than expected).
Fields of papers citing papers by Sha Yi
This network shows the impact of papers produced by Sha Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sha Yi. The network helps show where Sha Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Sha Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 92 | |
| 2 | 2016 | 71 | |
| 3 | 2020 | 51 | |
| 4 | 2004 | 44 | |
| 5 | 2012 | 39 | |
| 6 | 2012 | 34 | |
| 7 | 2019 | 33 | |
| 8 | 2005 | 32 | |
| 9 | 2014 | 31 | |
| 10 | 2001 | 30 | |
| 11 | 2007 | 28 | |
| 12 | 2011 | 26 | |
| 13 | 2017 | 24 | |
| 14 | 2006 | 24 | |
| 15 | 2020 | 24 | |
| 16 | 2015 | 23 | |
| 17 | 2014 | 19 | |
| 18 | 2001 | 18 | |
| 19 | A new cyclotetrapeptide from marine fungus Trichoderma reesei. | 2006 | 16 |
| 20 | 2010 | 15 |
About Sha Yi
Sha Yi is a scholar working on Molecular Biology, Plant Science, Cancer Research, Organic Chemistry and Pharmacology, having authored 59 papers that have together received 856 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (14 papers), Phytochemistry and Biological Activities (7 papers), Sesquiterpenes and Asteraceae Studies (5 papers), Biological Activity of Diterpenoids and Biflavonoids (5 papers), Plant Toxicity and Pharmacological Properties (4 papers), Cancer-related Molecular Pathways (4 papers), Bioactive Natural Diterpenoids Research (3 papers) and Retinoids in leukemia and cellular processes (3 papers). The work is most often cited by research in Molecular Biology (534 citations), Complementary and alternative medicine (57 citations), Pharmacology (61 citations), Toxicology (21 citations) and Cancer Research (67 citations). Sha Yi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Lijing Yang, Xian Li, Guohui Cui, Famei Li, Shuang Cai, Hailong Zhang, Taoguang Huo, Lubing Gu, Xiumei Lu and Mingyang Yu. Their work appears in journals such as Journal of Asian Natural Products Research, Chemical and Pharmaceutical Bulletin, International Immunopharmacology, Acta Pharmacologica Sinica and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.